160 related articles for article (PubMed ID: 27084958)
1. Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy.
van der Valk FM; Bernelot Moens SJ; Verweij SL; Strang AC; Nederveen AJ; Verberne HJ; Nurmohamed MT; Baeten DL; Stroes ES
Ann Rheum Dis; 2016 Oct; 75(10):1848-51. PubMed ID: 27084958
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.
Rollefstad S; Ikdahl E; Hisdal J; Kvien TK; Pedersen TR; Holme I; Semb AG
Ann Rheum Dis; 2015 Aug; 74(8):1544-50. PubMed ID: 24699940
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
Hoogeveen RM; Verweij SL; Kaiser Y; Kroon J; Verberne HJ; Vogt L; Moens SJB; Stroes ESG
Sci Rep; 2021 Feb; 11(1):4126. PubMed ID: 33602971
[TBL] [Abstract][Full Text] [Related]
5. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
6. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
[TBL] [Abstract][Full Text] [Related]
7. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
8. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
[TBL] [Abstract][Full Text] [Related]
9. Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation.
Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee JS; Lee PH; Lee SW; Lee CW
Medicine (Baltimore); 2021 Mar; 100(10):e25114. PubMed ID: 33725908
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
11. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
Soedamah-Muthu SS; Livingstone SJ; Charlton-Menys V; Betteridge DJ; Hitman GA; Neil HA; Bao W; DeMicco DA; Preston GM; Fuller JH; Stehouwer CD; Schalkwijk CG; Durrington PN; Colhoun HM;
Diabetologia; 2015 Jul; 58(7):1494-502. PubMed ID: 25899452
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
[TBL] [Abstract][Full Text] [Related]
14. Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.
Zardi EM; Pipita ME; Giorgi C; Lichinchi D; Zardi DM; Afeltra A
Medicine (Baltimore); 2018 Jul; 97(27):e11250. PubMed ID: 29979389
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
16. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation.
Komatsu T; Ayaori M; Uto-Kondo H; Hayashi K; Tamura K; Sato H; Sasaki M; Nishida T; Takiguchi S; Yakushiji E; Nakaya K; Ikewaki K
J Atheroscler Thromb; 2022 May; 29(5):775-784. PubMed ID: 33952812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]